Opportunity for Public Comment on Revisions to USP 797 Pharmaceutical Compounding
On Sept. 25, 2015, the U.S. Pharmacopeial Convention (USP) Compounding Expert Committee pre-posted revisions to General Chapter 797 Pharmaceutical Compounding – Sterile Preparations for public comment. The purpose of these revisions is to clarify requirements, reflect stakeholder feedback, and incorporate new information. The proposed revisions will be published for public comment in Pharmacopeial Forum (PF) 41(6) [Nov.–Dec. 2015] on Nov. 2, 2015.
The USP will hold an open microphone web meeting on Wednesday, Oct. 21, 2015 at 2 p.m. ET to discuss the proposed revisions.
More information about the proposed revisions and how to submit public comments can be found on the USP website.
The proposed revisions with line numbers can be viewed
.
Registration information for the open microphone meeting can be found here.
Source: CDC
CDC Strategies Preventing Hospital-Onset C difficile Effectiveness Inconclusive in Testing
April 15th 2024Hospitals using CDC prevention strategies had different incidences of hospital-associated Clostridioides difficile infection compared to those that didn't, but the reasons are not necessarily the strategies themselves.
